← 返回事件
持续讨论商业法务

Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy

发生了什么

Novo says Lilly's TV and social media campaigns cite outdated trial data to make Zepbound and Mounjaro look more effective than rival injections

摘要按规则整理自下方来源原文

来源